Clik here to view.
What’s up Medivation, MercadoLibre and Aeropostale?
In this report: Medivation Inc. (NASDAQ:MDVN), MercadoLibre Inc. (NASDAQ:MELI) and Aeropostale Inc. (NYSE:ARO). Medivation Inc. (NASDAQ:MDVN) has soared by more than 116 percent today after the...
View ArticleClik here to view.
What’s up Medivation, Acorda Therapeutics and DragonWave?
IN THIS REPORT: Medivation (NASDAQ:MDVN), Acorda Therapeutics Inc. (NASDAQ:ACOR) and DragonWave Inc. (NASDAQ:DRWI). Medivation (NASDAQ:MDVN) gained another 5 percent on Friday following its 113 point...
View ArticleClik here to view.
Soaring stocks and the reasons why (MRO, MDVN, WHR)
In this report: Marathon Oil (NYSE:MRO), Medivation (NASDAQ:MDVN) and Whirlpool Corp. (NYSE:WHR). Marathon Oil (NYSE:MRO) is trading nearly 4 percent higher today after the company announced that it...
View ArticleThursday’s Top Gainer Stocks- NASDAQ:IPSU, NASDAQ:MDVN, NASDAQ:KTOS
Shares of Imperial Sugar Company (NASDAQ:IPSU) increased 12 percent following private equity firm Arlon Group decided to take a stake in the firm’s Wholesome Sweeteners unit. NASDAQ:IPSU stock reported...
View ArticleHealthcare Stocks Gets Investors Affection; Medivation Wins Approval for...
Investors reacted positively to the Healthcare stocks on Friday. Major movement was seen in Medivation, Inc (NASDAQ:MDVN) and Threshold Pharmaceuticals, Inc (NASDAQ:THLD) on gainers side while Sucampo...
View ArticleHealthcare Sector Ends in Positive Territory; Medivation (NASDAQ:MDVN) Wins...
Healthcare sector responded positively on Friday’s trading session and sector climbed +0.30%. If we look at the top movers of the sector so Neuralstem, Inc (NYSEAMEX:CUR) and Idera Pharmaceuticals Inc...
View ArticleDendreon’s (NASDAQ:DNDN) Provenge Sales Hikes 27% in the Q3; Stock Lifts –...
Dendreon Corporation (NASDAQ:DNDN) reported on Friday that revenue from its prostate cancer therapy Provenge moved up 27% in the Q3. Shares of the company hiked 16% after the report. Dendreon’s...
View ArticleDendreon (NASDAQ:DNDN) Swings to Loss in Fiscal Q4; Stock Tumbles – DNDN,...
Dendreon Corporation (NASDAQ:DNDN) on Monday announced a quarterly loss evaluated against a profit in previous year as revenue tumbled and restructuring expenses weighed on the biotechnology...
View Article
